Zansecimab
Zansecimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Zansecimab is under investigation in clinical trial NCT04342897 (A Study of LY3127804 in Participants With COVID-19).
| Trade Name | Zansecimab |
| Generic | Zansecimab |
| Zansecimab Other Names | Zansecimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Zansecimab works
Zansecimab is a humanized IgG4 isotype antibody that neutralizes phospho-Tie2 induction due to Ang2, thereby stopping angiogenesis. The mechanism behind the neutralization is due to the antibody binding with high affinity to, and inhibiting Ang2.
Innovators Monograph
You find simplified version here Zansecimab
